GGrantIndex
Sort

53,477 grants matching addiction

Oral v Injection Naltrexone in Hospital: Comparative Effectiveness for Alcoholism

$880,488
Richard Saitz · Boston University Medical Campus · R01 · FY2015 · AA

VitC to Decrease Effects of Smoking in Pregnancy on Infant Lung Function-CCC-Lead

$880,398
Cynthia T McEvoy · Oregon Health & Science University · R01 · FY2012 · HL

Digital Therapeutic Development of Virtual Cognitive-Affective Training for Opioid Use Disorder

$880,335
Risa B Weisberg · Behavr, Llc · R44 · FY2022 · DA

Development of Mu Agonist Delta Antagonist Opioids as Analgesics for Chronic Pain

$880,230
Corinne Elizabeth Augelli-Szafran · Southern Research Institute · R01 · FY2019 · DA

Clinical Trials Network, Ohio Valley Node U10DA013732

$880,000
T John Winhusen · University Of Cincinnati · U10 · FY2012 · DA

VitC to Decrease Effects of Smoking in Pregnancy on Infant Lung Function-CCC-Lead

$880,000
Cynthia T McEvoy · Oregon Health & Science University · R01 · FY2015 · HL

Development of Mu Agonist Delta Antagonist Opioids as Analgesics for Chronic Pain

$879,889
Subramaniam Ananthan · Southern Research Institute · R01 · FY2016 · DA

Short-term and long-term effects of methamphetamine exposure on residual viral transcription during treated HIV disease

$879,803
Sulggi Angela Lee · University Of California, San Francisco · R33 · FY2024 · DA

VitC to Decrease Effects of Smoking in Pregnancy on Infant Lung Function-CCC-Lead

$879,684
Cynthia T McEvoy · Oregon Health & Science University · R01 · FY2016 · HL

Electrophysiological and electrochemical studies of addictive drugs

$879,029
Eugene A Kiyatkin · National Institute On Drug Abuse · ZIA · FY2024 · DA

Computational Methods for Identification of Genetic Factors Affecting the Response to Drug Abuse

$878,896
Gary A Peltz · Stanford University · U01 · FY2019 · DA

Discovery and development of GPR3 agonists for nicotine cessation

$878,861
Elaine Arrington Gay · Research Triangle Institute · R01 · FY2023 · DA

Interdisciplinary Research Training in Pain and/or Substance Use Disorders

$878,852
Sean C Mackey · Stanford University · T32 · FY2024 · DA

Establishment and Characterization of Novel Mutant Mouse Models for the Addiction Research Community

$877,994
Vivek Kumar · Jackson Laboratory · U01 · FY2025 · DA

Cerebral Structural and Metabolic Correlates of Aggressive or Addictive Behavior

$877,893
Markus Heilig · National Institute On Alcohol Abuse And Alcoholism · ZIA · FY2013 · AA

Discovery and validation of novel targets for pharmacotherapy of alcoholism

$877,893
Markus Heilig · National Institute On Alcohol Abuse And Alcoholism · ZIA · FY2013 · AA

Increasing available choices for conjugate vaccine technology by producing carrier proteins in Scarab Genomics’ reduced genome E. coli strains

$877,755
Frederick R Blattner · Scarab Genomics, Llc · R44 · FY2017 · AI

Repressive Histone and DNA Methylation in Stimulant and Opiate Addiction

$877,198
Eric J Nestler · Icahn School Of Medicine At Mount Sinai · P01 · FY2018 · DA

Structure and Function of CB2 Receptor

$877,195
Alexandros Makriyannis · Northeastern University · R01 · FY2017 · DA

CTN New England Consortium Node

$877,035
Gail D'onofrio · Yale University · UG1 · FY2025 · DA

Pioglitazone for the Treatment of Opioid and of Nicotine Dependence

$877,017
Sandra D. Comer · New York State Psychiatric Institute Dba Research Foundation For Mental Hygiene, Inc · R01 · FY2011 · DA

VitC to Decrease Effects of Smoking in Pregnancy on Infant Lung Function-CCC-Lead

$876,741
Cynthia T McEvoy · Oregon Health & Science University · R01 · FY2014 · HL

Next generation all-optical toolkits for functional analysis of neuropeptide dynamics in neural circuits

$876,703
Matthew R. Banghart · University Of California, San Diego · U01 · FY2021 · NS

HIV/STI Prevention for Drug-Involved Couples

$876,617
Louisa Gilbert · Columbia Univ New York Morningside · R01 · FY2008 · DA

Molecular Pathogenesis of Multiple Myeloma

$876,500
Walter Kuehl · Division Of Clinical Sciences - Nci · ZIA · FY2011 · CA